For an adult patient without significant cardiopulmonary disease, which volatile inhalation anesthetic agents are preferred, what are their typical end‑tidal concentrations, and what are the key considerations and alternatives?

Volatile Inhalation Anesthetics for Adults Without Cardiopulmonary Disease

Preferred Agents

For adult patients without significant cardiopulmonary disease, sevoflurane, isoflurane, and desflurane are the preferred volatile anesthetic agents, with sevoflurane offering the smoothest induction and desflurane providing the fastest emergence, while isoflurane remains cost-effective for longer procedures. 1, 2, 3

Typical End-Tidal Concentrations (MAC Values)

Sevoflurane

• Age 25 years: 2.0% (with 100% O₂) or 1.4% (with 60% N₂O) 4
• Age 45 years: Approximately 1.7-1.8% (with 100% O₂) 4
• Age 70 years: Approximately 1.4% (with 100% O₂) 4
• Maintenance typically requires 1.5-3% end-tidal concentration 2, 3

Isoflurane

• Age 25 years: Approximately 1.2% (with 100% O₂) 4
• Age 45 years: Approximately 1.0% (with 100% O₂) 4
• Maintenance typically requires 1.0-2.0% end-tidal concentration 2, 3

Desflurane

• Age 25 years: 7.3% (with 100% O₂) or 4.0% (with 60% N₂O) 5
• Age 45 years: 6.0% (with 100% O₂) or 2.8% (with 60% N₂O) 5
• Age 70 years: 5.2% (with 100% O₂) or 1.7% (with 60% N₂O) 5
• Maintenance typically requires 2.5-8.5% end-tidal concentration 5

Key Considerations by Agent

Sevoflurane

• Provides the smoothest, most pleasant induction with minimal airway irritation, making it suitable when mask induction is preferred 4, 2
• Rapid onset and recovery due to low blood-gas solubility 4, 3
• Minimal cardiovascular depression compared to halothane 4
• Metabolism produces fluoride ions (5-9% metabolized), but subnephrotoxic levels in normal use 4, 6
• Stable cardiac rhythm without significant arrhythmogenic potential 4

Isoflurane

• Most cost-effective option for longer procedures when rapid emergence is not critical 2, 3
• Airway irritability precludes rapid mask induction despite favorable pharmacokinetics 4
• Maintains myocardial contractility and stable cardiac rhythm, though may cause tachycardia 4
• Minimal metabolism (<5%), reducing risk of organ toxicity 4, 6
• Preferred agent for neurosurgical procedures 4

Desflurane

• Fastest emergence and recovery, particularly beneficial in obese patients (BMI ≥30 kg/m²) 7, 2, 3
• Severe airway irritation makes it unsuitable for mask induction; requires IV induction first 5, 2
• May cause transient hypertension and tachycardia during rapid concentration increases 7, 5
• Minimal metabolism (<0.02%), virtually no fluoride production 2, 6
• Requires specialized heated vaporizer due to low boiling point 5, 3

Cardioprotective Effects

All volatile anesthetics provide cardioprotection through preconditioning and postconditioning mechanisms, decreasing troponin release and preserving left ventricular function compared to propofol-based techniques. 1

• Cardioprotection occurs at low doses (0.25-0.5 MAC) of sevoflurane and isoflurane 1
• Continuous administration throughout surgery is more effective than intermittent use for cardioprotection 1
• Benefits demonstrated in cardiac surgery can be generalized to patients with coronary artery disease undergoing noncardiac surgery 1

Common Cardiovascular Effects

All Volatile Agents Share:

• Depression of myocardial contractility in dose-dependent fashion 1
• Afterload reduction through vasodilation 1
• Dose-dependent decreases in blood pressure during maintenance 5
• Similarities between agents are greater than their differences 1

Agent-Specific Hemodynamic Profiles:

• Isoflurane and sevoflurane: Reduce systemic vascular resistance more than contractility 4
• Desflurane: May increase heart rate above 1 MAC, making tachycardia an unreliable sign of inadequate anesthesia 5

Alternatives and Special Situations

Total Intravenous Anesthesia (TIVA) with Propofol

• Consider TIVA when volatile anesthetics are contraindicated: malignant hyperthermia susceptibility, severe airway irritability, or lack of appropriate vaporizer 8
• Propofol reduces postoperative nausea and vomiting compared to volatile agents, particularly important in high-risk patients 8
• Does not provide the same cardioprotective effects as volatile anesthetics in patients with coronary artery disease 1
• Requires depth-of-anesthesia monitoring (BIS 40-60) to prevent awareness when combined with neuromuscular blockade 8, 9

Nitrous Oxide Supplementation

• Reduces MAC requirements by approximately 40-50% when used at 60% concentration 5, 4
• Allows lower concentrations of volatile agents, potentially reducing cardiovascular depression 5
• Contraindicated in closed air spaces (pneumothorax, bowel obstruction) and may increase postoperative nausea 4

Critical Pitfalls to Avoid

Induction Errors

• Never use desflurane for mask induction due to severe airway irritation causing coughing, breath-holding, and laryngospasm 5, 2
• Rapid increases in desflurane concentration (>1% per breath) can cause sympathetic stimulation with hypertension and tachycardia 5
• Sevoflurane induction requires gradual increases (0.5-1% increments every 2-3 breaths) to minimize airway irritation 5

Maintenance Errors

• Excessive depth causes hypotension that should be corrected by decreasing inspired concentration, not solely with vasopressors 5
• Concentrations >12% dilute oxygen and may require reduction of nitrous oxide or air to maintain adequate FiO₂ 5
• Failure to account for age-related MAC reduction leads to overdosing in elderly patients 5, 4

Monitoring Failures

• Alveolar concentration lags inspired concentration by approximately 10% at fresh gas flows ≥2 L/min 5
• Increased heart rate with desflurane is not a reliable sign of inadequate anesthesia unlike with other agents 5
• BIS monitoring (target 40-60) should guide dosing, especially in elderly patients 7, 9

Drug Interactions

• Benzodiazepines and opioids decrease MAC requirements by 25-50%, necessitating dose reduction 5
• Volatile agents potentiate neuromuscular blockade, requiring reduced doses of muscle relaxants 5
• Concomitant propofol administration (as seen in cardiac surgery) may negate cardioprotective benefits of volatile agents 1, 8

Practical Algorithm for Agent Selection

Step 1: Assess Induction Method

• If mask induction planned: Use sevoflurane (smooth, non-irritating) 4, 2
• If IV induction planned: Any agent acceptable; proceed to Step 2 5, 2

Step 2: Evaluate Procedure Duration and Patient Factors

• Short procedures (<1 hour) or obese patients: Prefer desflurane for rapid emergence 7, 3
• Long procedures (>2 hours) in cost-conscious setting: Prefer isoflurane for economy 2, 3
• Intermediate duration or balanced priorities: Sevoflurane offers middle ground 2, 3

Step 3: Consider Cardiovascular Status

• Known coronary artery disease: Prefer volatile agents over TIVA for cardioprotection; use sevoflurane or isoflurane at 0.5-1 MAC throughout 1
• Hemodynamic instability concerns: All volatile agents cause similar cardiovascular depression; consider opioid supplementation to reduce volatile requirements 1

Step 4: Account for Special Contraindications

• Malignant hyperthermia susceptibility: Use TIVA with propofol; avoid all volatile agents 1
• Severe reactive airway disease: Avoid desflurane; prefer sevoflurane for bronchodilation 7
• High PONV risk: Consider TIVA with propofol instead of volatile agents 8